Will Ozempic and other GLP-1 Inhibitors go down as the Opioid crisis of the 2020s?
Are there people for whom these drugs are more dangerous?
If so, is it predictable who these people are?
Are doctors overprescribing GLP-1 inhibitors?
Is there a financial incentive for the doctors to do it even when it's not advisable for the patient?
Is there a penalty for docs doing this?
Should there be?
These drugs are now approved for children as young as 12 years old, it's not long before we're approving it for 6 year olds, how long before we have a generation of people who know nothing of food and exercise personal responsibility?
These are just some of the questions discussed on today's episode with Dr. Spencer Nadolsky.
It should be noted, Dr. Nadolsky is a professional, and a good person who wants the best for his patients and his industry. Him coming on this show to discuss this topic demonstrates high integrity and willingness to go the extra mile. We need more docs like him.
Find doc on instagram at @drnadolsky
The Active Life Podcast